The Implantable Cardioverter Defibrillator Remains the First Choice for Primary Prevention of Sudden Death in Non-Ischemic Dilated Cardiomyopathy in the Current Era of Treatment

pp. 212-219

Authors

  • Carlos Labadet Head of Electrophysiology in Centro de Educación Médica e Investigaciones Clínicas “Norberto Quirno” (CEMIC), Autonomous City of Buenos Aires, Argentina https://orcid.org/0000-0001-6989-0097
  • Arturo Cagide Hospital Italiano de Buenos Aires, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.7775/rac.es.v93.i3.20893

Published

2025-07-28

Issue

Section

CONTROVERSIAS

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >>